Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages
about
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerDuality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad copMycobacterium tuberculosis and the host cell inflammasome: a complex relationshipDifferential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infectionsVersatile myeloid cell subsets contribute to tuberculosis-associated inflammationImmunometabolism in TuberculosisReverse translation in tuberculosis: neutrophils provide clues for understanding development of active diseaseGranulomas and Inflammation: Host-Directed Therapies for Tuberculosis.Disease-promoting effects of type I interferons in viral, bacterial, and coinfectionsSensing of Mycobacterium tuberculosis and consequences to both host and bacillusAllele-specific induction of IL-1β expression by C/EBPβ and PU.1 contributes to increased tuberculosis susceptibilityCutting edge: Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-β and AIM2 inflammasome-dependent IL-1β production via its ESX-1 secretion systemInterferon alpha treatment of patients with impaired interferon gamma signaling.Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages.Insights into battles between Mycobacterium tuberculosis and macrophages.Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages.Autophagy in tuberculosisComparative functional genomics and the bovine macrophage response to strains of the mycobacterium genus.Interleukin-1 and interferon-γ orchestrate β-glucan-activated human dendritic cell programming via IκB-ζ modulation.Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancersDefining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse modelCytokine and lipid mediator networks in tuberculosisSoluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitroInflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate AutophagyESX-1 exploits type I IFN-signalling to promote a regulatory macrophage phenotype refractory to IFNγ-mediated autophagy and growth restriction of intracellular mycobacteria.Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis.IL-27 Suppresses Antimicrobial Activity in Human Leprosy.Mucosal vaccination with attenuated Mycobacterium tuberculosis induces strong central memory responses and protects against tuberculosisSystematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulenceActivation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia.Functional genomics identifies type I interferon pathway as central for host defense against Candida albicansType I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages.Type I Interferon Counters or Promotes Coxiella burnetii Replication Dependent on Tissue.Pathways of IL-1β secretion by macrophages infected with clinical Mycobacterium tuberculosis strains.Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection.Low Dose BCG Infection as a Model for Macrophage Activation Maintaining Cell Viability.
P2860
Q26795466-1D7A7E22-7331-44DF-8BF6-615333DE379DQ26823530-6AB2F7AA-FCBF-4591-B016-6A9A5EA47B83Q26825637-73AA70AA-1F68-4B1E-B5B4-18E7EE4A807FQ26849516-15307D6C-DC1C-45B9-B939-15D5F9C41792Q26997007-C51DE010-432A-47F0-B654-5ADCCBAC12C6Q27021247-B9103F2E-3052-443E-AEC4-79BCD61C03F4Q27027976-1824C1BE-638B-4DCA-A35C-C544FC2D701BQ28076037-AB0FC44A-2535-4AD8-AB86-0F0846A904B1Q28082841-59D2CE5B-758B-4B33-B8DB-E9191F7DF66DQ28085251-BB0C35BB-4FF2-4DEA-A30F-B086605405B4Q28396007-2918B1F1-ACD5-421F-8788-ECC13364ACE5Q28587403-7595761E-61F0-4C60-8551-E8C9F204B84AQ34059742-61A877D2-7AC8-4166-A218-9D2245CED8A5Q34164176-3B8CB036-7038-476F-BD3F-06A44F9F76F8Q34222028-283E4253-0DF0-47D5-9BCE-E49CF1657A3AQ34268873-ECB6C4AA-27AA-439F-BEBC-EED6F6B121CAQ34275913-944E84F1-541D-4C92-BF18-9BF0D03B721DQ34400283-C05D78FB-B9BA-4E54-AE8E-6E1D387C7C73Q34454941-D1A8645B-1E40-47E0-845C-55AFFBC688C6Q34634678-E500151F-EEC7-477B-9123-D7E548FA7244Q34935542-06D98708-CD39-489F-ACE3-C464F9FEE833Q35053675-149DF66E-B44C-4D6F-B37F-655B66DBEF44Q35117086-56C92729-5845-437C-B8F1-C9C55888CA9BQ35531082-67E80602-BF5C-481C-BC71-C487752DEF43Q35566819-D65AFA10-0206-46D0-8A89-BC8FE144F652Q35634587-8FC9F10F-3B3C-4A86-B99F-E36180C244B0Q35738682-4DE85B36-D7AF-4AFB-86C5-2521449964E1Q35984874-8A078AFB-B76B-4777-9BF0-E9B36612B1F1Q36019386-E09268A8-F8B0-49CC-BA27-11FE376786FAQ36054382-AE714684-0C5F-46EA-9A90-27072AF2A357Q36169358-AF7488BA-C003-465C-9F2D-6ED1424E28ECQ36372063-AE6095A4-2E06-49D4-9A04-0696D74C1C5CQ36733472-9B4E5A4D-07DB-449B-8D74-AC0029CD4873Q36762802-9EDCD292-38ED-43A0-830F-0102F87E7BBFQ36842908-529BD157-10A9-4886-9EA5-92FF6C5CE653Q36954627-87521B1B-ED45-4385-B940-D76F5494005FQ37002305-ADB944EB-1D68-4615-B2BB-9B1808CFD6F2Q37138980-E0FA9D96-188B-4561-B864-A5D57872E2F6Q37298109-CAB25EDE-1849-4E7D-91F5-15126B8F2D98Q37385874-B4CAE7D1-3B50-4979-B08B-DE3D4B8A9182
P2860
Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mycobacterium tuberculosis tri ...... roduction in human macrophages
@ast
Mycobacterium tuberculosis tri ...... roduction in human macrophages
@en
type
label
Mycobacterium tuberculosis tri ...... roduction in human macrophages
@ast
Mycobacterium tuberculosis tri ...... roduction in human macrophages
@en
prefLabel
Mycobacterium tuberculosis tri ...... roduction in human macrophages
@ast
Mycobacterium tuberculosis tri ...... roduction in human macrophages
@en
P2093
P2860
P356
P1476
Mycobacterium tuberculosis tri ...... roduction in human macrophages
@en
P2093
Aleksey Novikov
Carl G Feng
Giorgio Trinchieri
Katrin D Mayer-Barber
Kevin D Kirschman
Kevin Shenderov
Marco Cardone
Robert Thompson
Ronald L Rabin
P2860
P304
P356
10.4049/JIMMUNOL.1100926
P407
P577
2011-07-22T00:00:00Z